Ran Harpaz
First SEC filing: Oct. 8, 2021 · Latest: Oct. 8, 2021
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 15, 2022 | HIPO | F | 751 | $14.41 | $10,822 | 162,599 Direct | -0.46% | Disposed | 125.4% (price as of 2026-10-06) |
| Aug. 15, 2022 | HIPO | F | 18,740 | $0.99 | $18,553 | 4,083,771 Direct | -0.46% | Disposed | 31.2% (price as of 2026-10-06) |
| June 6, 2022 | HIPO | A | 1,150,000 | · | · | 4,102,511 Direct | +38.95% | Acquired | (price as of 2026-10-06) |
| May 16, 2022 | HIPO | F | 18,637 | $1.62 | $30,192 | 2,952,511 Direct | -0.63% | Disposed | -19.8% (price as of 2026-10-06) |
| April 12, 2022 | HIPO | A | 665,500 | · | · | 2,971,148 Direct | +28.86% | Acquired | (price as of 2026-10-06) |
| April 12, 2022 | HIPO | A | 2,684,121 | · | · | 2,684,121 Direct | · | Acquired | (price as of 2026-10-06) |
| Nov. 9, 2021 | HIPO | A | 201,523 | · | · | 2,305,648 Direct | +9.58% | Acquired | (price as of 2026-10-06) |
| Sept. 10, 2021 | HIPO | A | 369,760 | · | · | 369,760 Direct | · | Acquired | (price as of 2026-10-06) |
| Aug. 4, 2021 | HIPO | A | 173,858 | · | · | 173,858 Direct | · | Acquired | (price as of 2026-10-06) |
| Aug. 4, 2021 | HIPO | D | 300,000 | · | · | 2,104,125 Direct | -12.48% | Disposed | (price as of 2026-10-06) |
| Aug. 4, 2021 | HIPO | A | 2,404,125 | · | · | 2,404,125 Direct | · | Acquired | (price as of 2026-10-06) |
| Aug. 4, 2021 | HIPO | A | 173,858 | · | · | 173,858 Direct | · | Acquired | (price as of 2026-10-06) |
| Aug. 4, 2021 | HIPO | D | 300,000 | · | · | 2,104,126 Direct | -12.48% | Disposed | (price as of 2026-10-06) |
| Aug. 4, 2021 | HIPO | A | 2,404,126 | · | · | 2,404,126 Direct | · | Acquired | (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 12, 2022 | HIPO | Stock Option (Right to Buy) | Common Stock | $1.90 | April 11, 2032 | 2,684,121 | Acquired |
| Sept. 10, 2021 | HIPO | Stock Option (Right to Buy) | Common Stock | $5.87 | Sept. 9, 2031 | 369,760 | Acquired |
| Aug. 4, 2021 | HIPO | Stock Option (Right to Buy) | Common Stock | $1.06 | Dec. 3, 2030 | 173,858 | Acquired |
| Aug. 4, 2021 | HIPO | Stock Option (Right to Buy) | Common Stock | $1.06 | Dec. 3, 2030 | 173,858 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $407,480 | · | · | · | · | · | $250,000 | $5,076,376 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.